{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:28:33Z","timestamp":1787225313461,"version":"build-2736575974"},"reference-count":24,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Arrhythmia recurrence after cryoballoon ablation remains a clinically relevant problem in atrial fibrillation (AF). However, factors associated with documented recurrence in low-risk patients without major comorbidities are not well defined. This study aimed to evaluate factors associated with documented arrhythmia recurrence after cryoballoon ablation in a highly selected low-risk AF population. Methods: This retrospective, single-center study included 153 eligible patients selected from an institutional cryoablation database after application of predefined exclusion criteria. Only patients with a CHA2DS2-VA (congestive heart failure, hypertension, age \u2265 75 years, diabetes mellitus, stroke\/transient ischemic attack\/thromboembolism, vascular disease, and age 65\u201374 years) score \u2264 1 and without major comorbidities, including diabetes mellitus, hypertension, coronary artery disease, chronic kidney disease, cerebrovascular disease, and heart failure, were included. Recurrence was defined as electrocardiographically documented AF or atrial tachyarrhythmia after the 3-month blanking period over 1 year of follow-up; Holter-detected episodes were required to last \u226530 s. The primary multivariable model included sex, age, AF type, and absolute left atrial diameter; a sensitivity model replaced absolute left atrial diameter with left atrial diameter indexed to body surface area (BSA). Results: The study population included 70 women (45.8%) and 83 men (54.2%). Paroxysmal AF was present in 125 patients (81.7%), whereas 28 patients (18.3%) had persistent AF. Documented arrhythmia recurrence occurred in 40 patients (26.1%). Female sex was more frequent in the recurrence group than in the no-recurrence group (62.5% vs. 39.8%, p = 0.013). The complete-case primary multivariable model included 126 patients with 36 recurrence events. Female sex was associated with documented arrhythmia recurrence (odds ratio [OR] 2.69, 95% confidence interval [CI] 1.14\u20136.37; p = 0.024). The estimate for left atrial diameter was directionally positive but statistically uncertain (OR 1.086 per mm, 95% CI 0.989\u20131.192; p = 0.085). In the BSA-indexed sensitivity model (n = 123), the female-sex estimate was attenuated and statistically uncertain (OR 2.16, 95% CI 0.90\u20135.18; p = 0.084), while left atrial diameter\/BSA was also statistically uncertain (OR 1.145 per mm\/m2, 95% CI 0.977\u20131.343; p = 0.095). Conclusions: In this selected low-risk cohort undergoing second-generation cryoballoon ablation, female sex was associated with clinically detected, electrocardiographically documented arrhythmia recurrence in the primary model under an intermittent rhythm-surveillance strategy based on scheduled 12-lead electrocardiograms (ECGs) and symptom-driven evaluations. However, the estimate was attenuated and statistically uncertain after indexing left atrial diameter to BSA. Given the retrospective, single-center design, non-systematic rhythm monitoring, and sensitivity of the sex estimate to body-size adjustment, these findings should be interpreted as hypothesis-generating.<\/jats:p>","DOI":"10.3390\/jcm15166448","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:55:18Z","timestamp":1787223318000},"page":"6448","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors Associated with Documented Arrhythmia Recurrence After Cryoballoon Ablation in a Low-Risk Atrial Fibrillation Population Without Major Comorbidities"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-5899","authenticated-orcid":false,"given":"Murat Erdem","family":"Alp","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3871-8248","authenticated-orcid":false,"given":"Veli","family":"Polat","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-4983","authenticated-orcid":false,"given":"S\u00fcleyman","family":"Barut\u00e7u","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6891-9457","authenticated-orcid":false,"given":"G\u00fcng\u00f6r \u0130layda","family":"Bostanc\u0131 Alp","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3777-872X","authenticated-orcid":false,"given":"Yaser","family":"\u0130slamo\u011flu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9857-0962","authenticated-orcid":false,"given":"Gazi","family":"\u00c7apar","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-628X","authenticated-orcid":false,"given":"Ey\u00fcp","family":"\u00d6zkan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylan","family":"Akg\u00fcn","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, 34480 \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Rienstra","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sagris, M., Vardas, E.P., Theofilis, P., Antonopoulos, A.S., Oikonomou, E., and Tousoulis, D. (2021). Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010006"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCOUTCOMES.111.962688","article-title":"Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993\u20132007","volume":"5","author":"Piccini","year":"2012","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4330\/wjc.v8.i3.267","article-title":"Prediction of atrial fibrillation development and progression: Current perspectives","volume":"8","author":"Vlachos","year":"2016","journal-title":"World J. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/jama.2024.22451","article-title":"Atrial Fibrillation: A Review","volume":"333","author":"Ko","year":"2025","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s00392-021-01978-w","article-title":"Biomarkers as predictors of recurrence of atrial fibrillation post ablation: An updated and expanded systematic review and meta-analysis","volume":"111","author":"Boyalla","year":"2022","journal-title":"Clin. Res. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Liu, F., Song, T., Hu, Q., Zhu, X., Zhao, H., Tan, Z., Yu, P., Ma, J., Luo, J., and Liu, X. (2023). Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.999845"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hermida, A., Burtin, J., Kubala, M., Fay, F., Lallemand, P.-M., Buiciuc, O., Lieu, A., Zaitouni, M., Beyls, C., and Hermida, J.-S. (2022). Sex differences in the outcomes of cryoablation for atrial fibrillation. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.893553"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.14744\/AnatolJCardiol.2023.2857","article-title":"Integrating the left atrium diameter to improve the predictive ability of the age, creatinine, and ejection fraction score for atrial fibrillation recurrence after cryoballoon ablation","volume":"27","author":"Taylan","year":"2023","journal-title":"Anatol. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s40001-024-02045-6","article-title":"Relationship between left atrial isolated surface area and early-term recurrence in patients with persistent atrial fibrillation after cryoballoon ablation","volume":"29","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10840-022-01430-7","article-title":"Role of CHA2DS2-VASc score in predicting atrial fibrillation recurrence in patients undergoing pulmonary vein isolation with cryoballoon ablation","volume":"66","author":"Rordorf","year":"2023","journal-title":"J. Interv. Card. Electrophysiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.hrthm.2014.12.034","article-title":"The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation","volume":"12","author":"Jacobs","year":"2015","journal-title":"Heart Rhythm."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Jiang, L.-Q., Zhong, Y.-H., Chen, X.-H., Xu, Z., Gong, K.-Z., and Zhang, F.-L. (2025). A nomogram integrating the CHA2DS2-VASc score for predicting atrial fibrillation recurrence following catheter ablation. BMC Cardiovasc. Disord., 25.","DOI":"10.1186\/s12872-025-05071-2"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/europace\/euaa041","article-title":"Predicting recurrent atrial fibrillation after catheter ablation: A systematic review of prognostic models","volume":"22","author":"Dretzke","year":"2020","journal-title":"Europace"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/europace\/euz179","article-title":"Sex-related differences in catheter ablation of atrial fibrillation: A systematic review and meta-analysis","volume":"21","author":"Cheng","year":"2019","journal-title":"Europace"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e006204","DOI":"10.1161\/CIRCEP.118.006204","article-title":"Impact of female sex on clinical outcomes in the FIRE AND ICE trial of catheter ablation for atrial fibrillation","volume":"11","author":"Kuck","year":"2018","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacep.2020.04.032","article-title":"Impact of female sex on clinical presentation and ablation outcomes in the CIRCA-DOSE study","volume":"6","author":"Yao","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Matteucci, A., Russo, M., Galeazzi, M., Pandozi, C., Bonanni, M., Mariani, M.V., Pierucci, N., La Fazia, V.M., Di Fusco, S.A., and Nardi, F. (2025). Impact of Ablation Energy Sources on Perceived Quality of Life and Symptom in Atrial Fibrillation Patients: A Comparative Study. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082741"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14779072.2026.2649159","article-title":"Beyond successful atrial fibrillation ablation: Unmet patient needs, quality-of-life gap and patients\u2019 perspective","volume":"24","author":"Matteucci","year":"2026","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/jce.16776","article-title":"Pentaspline Pulsed Field Ablation Versus High-Power Short-Duration\/Very High-Power Short-Duration Radiofrequency Ablation in Atrial Fibrillation: A Meta-Analysis","volume":"36","author":"Mariani","year":"2025","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/JBM.S81551","article-title":"Predictors of atrial fibrillation recurrence after cryoballoon ablation","volume":"6","author":"Aksu","year":"2015","journal-title":"J. Blood Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5603\/KP.a2016.0186","article-title":"Predictors of late atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation: A meta-analysis","volume":"75","author":"Quan","year":"2017","journal-title":"Kardiol. Pol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/ejh.70155","article-title":"Oral Anticoagulation After Atrial Fibrillation Ablation: An Updated Systematic Review and Meta-Analysis of 267,443 Patients","volume":"116","author":"Matteucci","year":"2026","journal-title":"Eur. J. Haematol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ozkan, E., Elcik, D., Barutcu, S., Kelesoglu, S., Alp, M.E., Ozan, R., Capar, G., Turkmen, O., Cinier, G., and Polat, V. (2023). Inflammatory markers as predictors of atrial fibrillation recurrence: Exploring the C-reactive protein to albumin ratio in cryoablation patients. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196313"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6448\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:06:42Z","timestamp":1787224002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":24,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166448"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166448","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}